Beneficial effect of rutin on oxonate-induced hyperuricemia and renal dysfunction in mice

Pharmacology

Volumn 92, Issue 1-2, 2013, Pages 75-83

  Chen, Yu Sheng ^a   Hu, Qing Hua ^a   Zhang, Xian ^a   Zhu, Qin ^a   Kong, Ling Dong ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Hypouricemic effect; Renal function improvement; Renal organic ion transporters; Rutin; Uromodulin

Indexed keywords

ALLOPURINOL; CREATININE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 9; MESSENGER RNA; NITROGEN; OCTAMER TRANSCRIPTION FACTOR 1; OCTAMER TRANSCRIPTION FACTOR 2; ORGANIC ANION TRANSPORTER 1; ORGANIC CATION CARNITINE TRANSPORTER; ORGANIC CATION TRANSPORTER; OTERACIL POTASSIUM; RUTOSIDE; TAMM HORSFALL GLYCOPROTEIN; UNCLASSIFIED DRUG; URATE; URATE TRANSPORTER 1; UREA; URIC ACID; CARNITINE TRANSPORTER 1; CARNITINE TRANSPORTER 2; CARRIER PROTEINS AND BINDING PROTEINS; MEMBRANE PROTEIN; ORGANIC CATION TRANSPORTER 1; URATE TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPERURICEMIA; KIDNEY DYSFUNCTION; KIDNEY FUNCTION TEST; MALE; MORNING DOSAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RENAL PROTECTION; TISSUE LEVEL; UPREGULATION; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL; CREATININE BLOOD LEVEL; DRUG MECHANISM; PROTEIN ANALYSIS; PROTEIN URINE LEVEL; URIC ACID URINE LEVEL;

ANIMALS; CARRIER PROTEINS; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HYPERURICEMIA; KIDNEY DISEASES; MALE; MEMBRANE PROTEINS; MICE; OCTAMER TRANSCRIPTION FACTOR-1; ORGANIC ANION TRANSPORT PROTEIN 1; ORGANIC ANION TRANSPORTERS; ORGANIC CATION TRANSPORT PROTEINS; OXONIC ACID; RNA, MESSENGER; RUTIN; UROMODULIN;

EID: 84884272654     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000351703     Document Type: Article

References (25)

1. Heinig M, Johnson RJ: Role of uric acid in hypertension, renal disease, and metabolic syndrome. Cleve Clin J Med 2006; 73: 1059-1064.
2. Choi HK, Ford ES: Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 2007; 120: 442-447.
3. Schlesinger N: Management of acute and chronic gouty arthritis: present state-of-theart. Drugs 2004; 64: 2399-2416.
4. Hammer B, Link A, Wagner A, Böhm M: Hypersensitivity syndrome during therapy with allopurinol in asymptomatic hyperuricemia with a fatal outcome. Dtsch Med Wochenschr 2001; 126: 1331-1334.
5. Terkeltaub RA: Gout. N Engl J Med 2003; 349: 1647-1655.
6. Hao HH, Shao ZM, Tang DQ, Lu Q, Chen X, Yin XX, Wu J, Chen H. Preventive effects of rutin on the development of experimental diabetic nephropathy in rats. Life Sci 2012; 91: 959-67.
7. Calabro ML, Tommasini S, Donato P, Stancanelli R, Raneri D, Catania S, Costa C, Villari V, Ficarra P, Ficarra R: The rutin/beta-cyclodextrin interactions in fully aqueous solution: spectroscopic studies and biological assays. J Pharm Biomed Anal 2005; 36: 1019-1027.
8. Middleton E, Kandaswami C, Theoharides TC: The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharm Rev 2000; 52: 673-751.
9. Ihme N, Kiesewetter H, Jung F, Hoffmann KH, Birk A, Muller A, Grutzne KI: Leg oedema protection from a buckwheat herb tea in patients with chronic venous insufficiency: a single-centre, randomised, double-blind, placebo-controlled clinical trial. Eur J Clin Pharmacol 1996; 50: 443-447.
10. Hu QH, Zhang X, Pan Y, Li YC, Kong LD: Allopurinol, quercetin and rutin ameliorate renal NLRP3 inflammasome activation and lipid accumulation in fructose-fed rats. Biochem Pharmacol 2012,84: 113-125.
11. Zhu JX, Wang Y, Kong LD, Yang C, Zhang X: Effects of Biota orientalis extract and its flavonoid constituents, quercetin and rutin on serum uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver. J Ethnopharmacol 2004; 93: 133-140.
12. Middleton E, Kandaswami C, Theoharides TC: The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharm Rev 2000; 52: 673-751.
13. Ohno I: Uricosuric agent. Nippon Rinsho 2008; 66: 743-747.
14. Eraly SA, Vallon V, Rieg T, Gangoiti JA, Wikoff WR, Siuzdak G, Barshop BA, Nigam SK: Multiple organic anion transporters contribute to net renal excretion of uric acid. Physiol Genomics 2008; 33: 180-192.
15. Dresser MJ, Leabman MK, Giacomini KM: Transporters involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters. J Pharm Sci 2001; 90: 397-421.
16. Hu QH, Jiao RQ, Wang X, Lv YZ, Kong LD: Simiao pill ameliorates urate underexcretion and renal dysfunction in hyperuricemic mice. J Ethnopharmacol 2010; 128: 685-692
17. Brown CDA, Sayer R, Windass AS, Haslam IS, De Broe ME, D'Haese PC, Verhulst A: Characterisation of human tubular cell monolayers as a model of proximal tubular xenobiotic handling. Toxicol Appl Pharm 2008; 233: 428-438.
18. Korkmaz A, Kolankaya D: Protective effect of rutin on the ischemia/reperfusion induced damage in rat kidney. J Surg Res 2010; 164: 309-315.
19. Dahan K, Devuyst O, Smaers M, Vertommen D, Loute G, Poux JM, Viron B, Jacquot C, Gagnadoux MF, Chauveau D, Buchler M, Cochat P, Cosyns JP, Mougenot B, Rider MH, Antignac C, Verellen-Dumoulin C, Pirson Y: A cluster of mutations in the UMOD gene causes familial juvenile hyperuricemic nephropathy with abnormal expression of uromodulin. J Am Soc Nephrol 2003; 14: 2883-2893.
20. Carroll JJ, Coburn H, Douglass R, Babson AL: A simplified alkaline phosphotungstate assay for uric acid in serum. Clin Chem 1971; 17: 158-160.
21. Li JM, Zhang X, Wang X, Xie YC, Kong LD: Protective effects of cortex fraxini coumarines against oxonate-induced hyperuricemia and renal dysfunction in mice. Eur J Pharmacol 2011; 666: 196-204.
22. Hosoyamada M, Ichida K, Enomoto A, Hosoya T, Endou H: Function and localization of urate transporter 1 in mouse kidney. J Am Soc Nephrol 2004; 15: 261-268.
23. Wang Y, Zhu JX, Kong LD, Yang C, Cheng CH, Zhang X: Administration of procyanidins from grape seeds reduces serum uric acid levels and decreases hepatic xanthine dehydrogenase/oxidase activities in oxonate-treated mice. Basic Clin Pharmacol Toxicol 2004; 94: 232-237.
24. Huang J, Wang S, Zhu M, Chen J, Zhu X: Effects of genistein, apigenin, quercetin, rutin and astilbin on serum uric acid levels and xanthine oxidase activities in normal and hyperuricemic mice. Food Chem Toxicol 2011; 49: 1943-1947.
25. Deguchi T, Kouno Y, Terasaki T, Takadate A, Otagiri M: Differential contributions of rOat1 (Slc22a6) and rOat3 (Slc22a8) to the in vivo renal uptake of uremic toxins in rats. Pharm Res 2005; 22: 619-627.